| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18596193 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 97 journal articles in the PubMed database | Email to a friend | | |
| Fujita K, Nozaki Y, Yoneda M, et al.
Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. [JOURNAL ARTICLE]
Gut 2008 Jul 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Xu P, Zhang XG, Li YM, et al.
Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats. [Journal Article]
J Zhejiang Univ Sci B 2006 Aug; 7(8):627-33.
Abstract | Full Citation | | Hong XZ, Li LD, Wu LM
Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic Fatty liver disease. [Journal Article]
Clin Exp Pharmacol Physiol 2007 Jan-Feb; 34(1-2):27-35.
Abstract | Full Citation | Find Related Articles | | Kitamura K, Tada S, Nakamoto N, et al.
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis. [Journal Article]
J Gastroenterol Hepatol 2007 Nov; 22(11):2022-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nanda K
Non-alcoholic steatohepatitis in children. [Journal Article, Review]
Pediatr Transplant 2004 Dec; 8(6):613-8.
Abstract | Full Citation | Find Related Articles | | Federico A, Niosi M, Vecchio Blanco CD, et al.
Emerging drugs for non-alcoholic fatty liver disease. [Journal Article]
Expert Opin Emerg Drugs 2008 Mar; 13(1):145-58.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Denda A, Endoh T, Kitayama W, et al.
Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats. [Journal Article]
Carcinogenesis 1997 Oct; 18(10):1921-30.
Abstract | Full Citation | Find Related Articles | | Assy N, Grozovski M, Bersudsky I, et al.
Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. [Journal Article]
World J Gastroenterol 2006 Jul 21; 12(27):4369-76.
Abstract | Full Citation | | Uto H, Nakanishi C, Ido A, et al.
The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet. [JOURNAL ARTICLE]
Hepatol Res 2005 Aug 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
